drugset / Trial / NCT01005719
Study to Compare Gastric Inhibition of Two Proton Pump Inhibitors (CL2008-18)(P07815)(COMPLETED)
RandomizedCrossoverOpen-labelTreatment
Summary
This study will determine differences between Proton Pump Inhibitors (PPI) formulations relative to their effects on gastric acidity.
Timeline
- Start
- 2009-09
- Primary completion
- 2010-01
- Completion
- 2010-01
Outcome
Met primary endpoint
registry analysis (superiority or other test); Zegerid vs Prevacid®; p = 0.0242; Wilcoxon (Mann-Whitney); NCT01005719 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lansoprazole | Other / unclassified | 15 mg | Oral |
| Subject | Omeprazole | Other / unclassified | 20 mg | Oral |
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 1100 mg | Oral |
Indications
No indication recorded.